Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later (original) (raw)

Nature Protocols volume 3, pages 427–434 (2008)Cite this article

Abstract

Since its first description 20 years ago, the tetrazolium-based colorimetric (MTT) assay using MT-4 cells for the detection of anti-HIV compounds has been widely used. This method, which remains popular, provides more information than more recently developed methods and, therefore, represents a useful methodology on its own or in combination with other screening systems. The replication of HIV in MT-4 cells is usually monitored 5 d after infection; therefore, this protocol can be divided into three steps: the infection (at day 0), an incubation period (5 d) and the evaluation (at day 5). The long-standing and intensive use of the MTT method has taught users of the limitations and, equally importantly, the unexpected advantages of the MT-4/MTT assay. The use of this method can be extended to antiviral testing of compounds against other cyto-destructive viruses.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Nakashima, H. et al. Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds. J. Virol. Methods 26, 319–329 (1989).
    Article CAS PubMed Google Scholar
  2. Pauwels, R. et al. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309–321 (1988).
    Article CAS PubMed Google Scholar
  3. Schols, D., Pauwels, R., Vanlangendonck, F., Balzarini, J. & De Clercq, E. A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells. J. Immunol. Methods 114, 27–32 (1988).
    Article CAS PubMed Google Scholar
  4. Jordan, A., Bisgrove, D. & Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868–1877 (2003).
    Article CAS PubMed PubMed Central Google Scholar
  5. Kutsch, O., Benveniste, E.N., Shaw, G.M. & Levy, D.N. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76, 8776–8786 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  6. Kutsch, O. et al. Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription. Antimicrob. Agents Chemother. 48, 1652–1663 (2004).
    Article CAS PubMed PubMed Central Google Scholar
  7. Miyoshi, I. et al. Type-C virus-producing cell-lines derived from adult T-cell leukemia. Gann Monogr. Cancer Res. 219–228 (1982).
  8. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
    Article CAS PubMed Google Scholar
  9. Scudiero, D.A. et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827–4833 (1988).
    CAS PubMed Google Scholar
  10. Roehm, N.W., Rodgers, G.H., Hatfield, S.M. & Glasebrook, A.L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 142, 257–265 (1991).
    Article CAS PubMed Google Scholar
  11. Dunigan, D.D., Waters, S.B. & Owen, T.C. Aqueous soluble tetrazolium/formazan MTS as an indicator of NADH- and NADPH-dependent dehydrogenase activity. Biotechniques 19, 640–649 (1995).
    CAS PubMed Google Scholar
  12. Salahuddin, S.Z. et al. Restricted expression of human T-cell leukemia–lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129, 51–64 (1983).
    Article CAS PubMed Google Scholar
  13. Bjorndal, A. et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71, 7478–7487 (1997).
    CAS PubMed PubMed Central Google Scholar
  14. Baba, M., Miyake, H., Okamoto, M., Iizawa, Y. & Okonogi, K. Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1. AIDS Res. Hum. Retroviruses 16, 935–941 (2000).
    Article CAS PubMed Google Scholar
  15. Reed, L.J. & Muench, H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27, 493–497 (1938).
    Google Scholar

Download references

Acknowledgements

We thank Mrs Kristien Erven for critical reading and fine editorial assistance.

Author information

Authors and Affiliations

  1. Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, Leuven, B-3000, Belgium
    Christophe Pannecouque, Dirk Daelemans & Erik De Clercq

Authors

  1. Christophe Pannecouque
    You can also search for this author inPubMed Google Scholar
  2. Dirk Daelemans
    You can also search for this author inPubMed Google Scholar
  3. Erik De Clercq
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toChristophe Pannecouque.

Rights and permissions

About this article

Cite this article

Pannecouque, C., Daelemans, D. & De Clercq, E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later.Nat Protoc 3, 427–434 (2008). https://doi.org/10.1038/nprot.2007.517

Download citation